v3.21.1
Consolidated Statements Of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (15,220,901) $ (12,518,377)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 76,834 70,400
Relief of related party advances (9,629)
Write-off of subscription receivable 7,447
Stock-based compensation 3,303,211 1,988,626
Changes in operating assets and liabilities:    
Accounts receivable (24,686) 76,497
Deferred expense 20,927
Insurance deposit (749,454)
Other current assets (63,613) (251,088)
Accounts payable 407,300 1,375,704
Accrued liabilities 3,550,163 128,055
Insurance reserve 780,147 984,450
Deferred revenues 11,251 11,044
Net cash used in operating activities (7,804,704) (8,113,762)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment and intangibles (2,247) (1,207)
Deposits and other (5,000)
Net cash used in investing activities (2,247) (6,207)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock 12,075,000
Proceeds from Warrant Exercises 873,403
Proceeds from exercise of stock options 107,316 81,459
Offering costs associated with underwriters in public offering (753,750)
Offering costs (33,165) (263,873)
Proceeds from note payable 2,004,175
Principal repayment of note payable (5,000)
Net cash provided by financing activities 2,073,326 12,012,239
Increase in cash and cash equivalents (5,733,625) 3,892,270
Cash and cash equivalents, beginning of period 10,657,140 6,764,870
Cash and cash equivalents, end of period 4,923,515 10,657,140
Supplemental disclosures of cash flow information:    
Cash paid for interest 11,329
Cash paid for income taxes 800 800
Non cash investing and financing activities:    
Related-party advances relieved 9,629
Subscription receivable written-off $ 7,447